mywealthgrid
Overview
Dashboard
My workspace
My PortfolioWatchlistsFollowingScreenersAlertsResearch
Discover
CompaniesSectorsIndicesMutual fundsInstitutional investorsCompareTrade trends
Market updates
ResultsAnnouncementsSearch filingsCalendarUpcoming listings
Sign in to save your work
Sign inSign up
Loading page…
GD

Godavari Drugs Ltd

BSE:GODAVARI
HealthcarePharmaceuticals & Biotechnology
₹118.1
-2.13%1 Oct close
Mkt cap
₹119 Cr
Watch Alert Compare
OverviewChartPeersProfit & lossBalance sheetCash flowRatiosShareholdingF&ODocumentsEventsAnnouncementsNotes
AnnualQuarterly

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ CrMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
7181648496123161160157113106
COGS——-49-65-77971301281218278
Gross profit—————263132363228
6776110143166161922232018
45456101110131210
OPM %5.9%5.6%5.9%6.6%6.3%8%7%6.2%8.5%10.4%9.7%
Depreciation———11122222
Interest23233334554
01100001111
Profit before tax23122675765
Tax11010221111
Tax %38.5%33.2%37.4%30.9%12.7%27.7%25.4%23.3%19.8%22.2%19.2%
12112454644
PAT margin %1.9%2.3%1.3%1.5%2.1%3.4%3.3%2.4%3.5%3.9%3.9%
EPS (₹)1.82.41.11.62.75.5757.45.85.4
EPS adjusted (₹)—————5.5757.45.84
Annual reportAnnual report for Mar 2016Annual report for Mar 2017Annual report for Mar 2018Annual report for Mar 2019Annual report for Mar 2020Annual report for Mar 2021Annual report for Mar 2022Annual report for Mar 2023Annual report for Mar 2024Annual report for Mar 2025Annual report for Mar 2026

₹ CrMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital8888810
Reserves172226313666
282034566276
395155403848
Total equity & liabilities91101121135143200
222625273330
CWIP109183057
Investments000000
6875879081114
Total assets91101121135143200

₹ CrMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
1111318111
-1-5-9-13-20-26
0-6-4-6837
Net cash flow011-0-012
Free cash flow-0645-9-26
CFO / Operating profit %13.5%99.4%133.3%138.4%94.7%7.1%

Compounded sales growth

7 years
3%
5 years
-3%
3 years
-13%
1 year
-7%

Compounded profit growth

7 years
19%
5 years
-0%
3 years
3%
1 year
-7%

Stock price CAGR

10 years
—
5 years
11%
3 years
7%
1 year
40%

Return on equity

7 years
—
5 years
12%
3 years
10%
Last year
5%